SI-BONE Price Target Raised to $26.00/Share From $25.00 by UBS

What happened

UBS raised its price target on SI-BONE to $26.00 per share from $25.00 and maintained a Buy rating on the stock, according to ratings actions reported by Benzinga.

Confirmed

Global impact / market context

A higher price target signals that UBS expects more upside in SI-BONE shares than before, which can draw attention from investors who follow analyst ratings and affect demand for the stock.

Analyst inference

Analyst price targets are common in stock research and reflect expected value over time. A one-dollar increase is modest and may reassure holders, but the Buy rating, not the small bump, carries most of the signal.

Analyst inference

What to watch

1. UBS maintained its Buy rating on SI-BONE while raising the price target to $26.00 from $25.00, so the rating stays unchanged. Confirmed
2. Watch whether other analysts revise their own SI-BONE price targets or ratings, which could reinforce or offset UBS's view. Proposed
3. Track SI-BONE's next financial results, since actual revenue and profit could confirm or weaken the case behind UBS's higher target. Analyst inference

Evidence

• Original source link unavailable